Delivery Order SPE2DB20D3101-SPE2DB22FH2G7
- Not listed
- This federal contract award is for the delivery of Januvia 100 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract award, valued at $5,026.83, is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, with a total potential value of $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle...
- This federal contract award is for the delivery of pharmaceutical products, including the drug Januvia, to the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,158.06, is a delivery order issued under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop...
- This federal contract award is for the delivery of pharmaceutical products, primarily the drug Januvia 100 mg tablets, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $7,001.84, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA, valued at up to $999,999,999.00 and running...
- This federal contract award is for the delivery of pharmaceutical products, including medications such as Januvia 100 mg tablets, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999.00 and running through November 2026....
- This federal contract award is for the delivery of Januvia 100 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,324.06, is a delivery order under the company's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to supply...
- This federal contract award is for the delivery of pharmaceutical products, primarily Januvia 100 mg tablets, to the Defense Logistics Agency (DLA). The contract, valued at $3,789.07, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of September 28, 2021. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery...
- This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of Januvia 100 mg tablets to support military healthcare programs. The $33,475.80 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of May 16, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999...
- This federal contract award is for the delivery of Januvia 100 mg tablets in quantities of 1,000 to the Defense Logistics Agency (DLA). The contract, valued at $15,213.42, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of September 1, 2023 and is a firm fixed-price delivery order. There is no set-aside designation mentioned in the information provided. Amerisourcebergen Drug Corp is...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a $1,091.46 firm-fixed-price delivery order for the supply of Januvia 100 mg tablets. The contract has an ultimate completion date of July 2, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,615.37 delivery order covers the supply of Januvia 100 mg tablets for the DLA Troop Support Medical program. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by Amerisourcebergen's parent company, Cencora, Inc., which serves as a primary vehicle for the...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB22FH2G7Delivery Order
This federal contract award is for the delivery of pharmaceutical products, including the drug Januvia 100 mg tablets, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not have a set-aside designation, indicating open competition. Amerisourcebergen is a subsidiary of the parent company Cencora, Inc., which also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 12/6/21 |